Australian shares are expected to slip into the red at market open Friday as investors follow losses from Wall Street overnight.
The Nasdaq and the S&P 500 shed 0.2% each on Thursday, with Tesla driving the losses following a drop in vehicle deliveries for 2024. The Dow Jones Industrial Average was down 0.4%.
In macroeconomic news, the commodity price index rose 0.6% month over month in December 2024 in special drawing rights (SDR) terms, following a revised 1.3% increase in the prior month, preliminary data from the Reserve Bank of Australia showed Thursday.
In corporate news, Imugene (ASX:IMU) dosed the first Australian patient in the Phase 1b clinical trial of its azer-cel therapy, which is being assessed as a potential treatment for non-Hodgkin's lymphoma.
Arcadium Lithium (ASX:LTM) and Livent entered into a second supplemental indenture on Jan. 1.
UBS Securities Australia ceased to be a substantial holder in SG Fleet Group (ASX:SGF).
Australia's benchmark index rose 0.5%, or 42.10 points, Thursday to close at 8,201.20.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.